Zhao, Shuang
Ching, Chi-Keong
Huang, Dejia
Liu, Yen-Bin
Rodriguez-Guerrero, Diego A.
Hussin, Azlan
Kim, Young-Hoon
Van Dorn, Brian
Zhou, Xiaohong
Singh, Balbir
Zhang, Shu
,
Funding for this research was provided by:
Medtronic
Article History
Received: 19 July 2023
Accepted: 20 February 2024
First Online: 22 March 2024
Declarations
:
: The protocol was approved by the ethics committee of the leading site (Fuwai Hospital, ethical number: 2014–525), each participating institution and associated national and local regulatory agencies. All patients provided written informed consent before undergoing the study procedures.
: Not applicable.
: S Zhao: none. CK Ching: speaker fees/steering committee fees—Medtronic. D Huang: speaker/consultant fees—Boston Scientific, St. Jude Medical. YB Liu: speaker fees/steering committee fees—Medtronic. DA. Rodriguez-Guerrero: proctor/lecture fees—Boston Scientific; proctorship—Biosense Webster, St. Jude Medical/Abbott; steering committee fees—Medtronic. A. Hussin: speaker fees/steering committee fees—Medtronic. YH. Kim: steering committee fees—Medtronic. B. Van Dorn: employment—Medtronic. XH Zhou: employment—Medtronic. B. Singh: steering committee fees—Medtronic. S. Zhang: speakers bureau/consulting fees—Boston Scientific, Medtronic, St. Jude Medical, Biotronik; steering committee fees—Medtronic.